Richard N Kender
CIK 1381205 · See Remarks · last filed 2026-07-10
Richard N Kender is a corporate insider who has filed 31 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for MCRB, was dated Jul 10, 2026. Current disclosed insider exposure totals $132.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$132.3K
6
31
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MCRB | See Remarks | 3,175 | $4.80 | $15.2K | $0 | 15 | 2026-07-10 |
| LGVN | Director | 33,000 | $0.60 | $19.8K | $0 | 2 | 2025-07-17 |
| BCYC | Director | 23,000 | $3.94 | $90.6K | $0 | 7 | 2025-01-06 |
| Omega Therapeutics, Inc. (OMGA) Delisted | Director | — | $0.14 | — | $0 | 1 | 2024-06-21 |
| INCR | Director | 7,148 | $0.92 | $6.6K | $0 | 4 | 2017-05-24 |
| ev3 Inc. (EVVV) Delisted | Director | 324 | — | — | $0 | 1 | 2007-10-09 |
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-10 | MCRB | Grant (A) | — | $0 | EDGAR |
| 2026-03-06 | MCRB | Grant (A) | — | $0 | EDGAR |
| 2025-07-17 | LGVN | Grant (A) | +17,000 | $0 | EDGAR |
| 2025-04-11 | MCRB | Grant (A) | — | $0 | EDGAR |
| 2025-01-06 | BCYC | Grant (A) | +6,250 | $0 | EDGAR |
| 2024-06-21 | Omega Therapeutics, Inc. (OMGA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-14 | LGVN | Grant (A) | +16,000 | $23.3K | EDGAR |
| 2024-04-08 | MCRB | Grant (A) | — | $0 | EDGAR |
| 2024-01-04 | BCYC | Grant (A) | +6,000 | $0 | EDGAR |
| 2023-06-23 | MCRB | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.